Clinical Trial

Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions

Study acronym: RespEcran
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2025 (before its estimated September 27, 2025 completion). Its status may not reflect the trial's current state.
Summary
The patients eligible for the study are those treated by radiotherapy on Linac MRI for a mobile cancerous lesion (pancreas, liver, kidneys, adrenals, lung, adenopathy above or below the diaphragm ...). After signing the consent form, each patient will be randomized to one of two treatment arms: * Standard arm : Radiotherapy treatment with Linac MRI without non-magnetic shielding * Experimental arm : radiotherapy treatment with Linac MRI with non-magnetic screen The aim is to evaluate the effect of using a non-magnetic screen visible to the patient in the bunker during radiotherapy sessions delivered by Linac MRI on decreasing the ratio between the actual treatment time and the treatment time predicted by the machine.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-23; most recent amendment 2025-02-14.
Status change: Not Yet Recruiting → Recruiting 2023-10-16
Trial Details
NCT Number NCT05783908
Lead Sponsor Centre Georges Francois Leclerc
Conditions Patient With Radiotherapy (Linac MRI), Mobile Cancerous Lesion
Enrollment 100 participants
Start Date 2023-10-16
Primary Completion 2025-09-27 (estimated)
Study Completion 2025-09-27 (estimated)
Updated on ClinicalTrials.gov 2025-02-17